Centene has appointed vice chair Sarah London as chief executive officer.
Ms. London has spent her career in healthcare innovation with a focus on advancing integrated, value-based care models through the development and application of data-driven insights and technology, according to a March 22 press release.
Prior to becoming CEO, Ms. London served as vice chair of the Centene board of directors. She led the company's technology and digital strategy and ran the healthcare enterprises and specialty divisions, corporate strategy, quality operations, internal audit, compliance and risk management. She has also been assisting with the day-to-day management of the company since February, when then-CEO Michael Neidorff took a leave of absence.
Before joining Centene in 2020, Ms. London was a partner at Optum Ventures, the venture capital arm of UnitedHealth Group. Prior to Optum Ventures, Ms. London served as chief product officer for Optum Analytics, the business unit responsible for driving strategy and commercialization of Optum's integrated data and analytics solutions into the provider, payer and life sciences markets.
"I am honored and humbled to have been selected as the next CEO of Centene and to work alongside extraordinary colleagues to provide quality healthcare to over 26 million Americans," said Ms. London. "The healthcare landscape is rapidly changing, and Centene's mission – to transform the health of our communities one member at a time – has never been more relevant."
Mr. Neidorff will remain on a previously announced medical leave of absence.